HHLA2 and pancreatic ductal adenocarcinoma: These results were consistent with previously reported points that HHLA2 could be used as an independent prognostic factor for renal clear cell carcinoma and intrahepatic cholangiocarcinoma (25), and high expression of HHLA2 was associated with better prognosis in pancreatic ductal adenocarcinoma (19).